Siderosis refers to the abnormal accumulation of iron in body tissue, and the term covers a surprisingly wide range of conditions depending on where that iron ends up. Used without qualification, it usually describes pulmonary siderosis, an occupational lung disease common among welders and metalworkers who breathe in iron-containing dust or fumes.1MalaCards. Siderosis But iron can also build up in the brain, the eye, the kidneys, the liver, or the spleen, and each location brings its own set of problems. Because the word gets used across so many specialties, understanding siderosis means understanding which organ is affected, how the iron got there, and what can be done about it.
Why Iron Becomes a Problem
Iron is essential for life. It carries oxygen in red blood cells and plays a role in hundreds of enzymatic reactions. The trouble starts when iron accumulates where it shouldn’t or in amounts the body can’t handle. Free iron reacts with hydrogen peroxide inside cells to produce highly reactive molecules, a process known as the Fenton reaction.2PubMed. Toxicity of iron and hydrogen peroxide: the Fenton reaction These reactive species damage proteins, fats, and DNA, which over time can injure or kill the cells they contact.3PubMed Central. Iron and oxidizing species in oxidative stress and Alzheimer’s disease This oxidative damage is the common thread linking all forms of siderosis, whether the iron entered through the lungs, the bloodstream, or a piece of shrapnel lodged in an eye.
Pulmonary Siderosis
Pulmonary siderosis, sometimes called welder’s lung, is the form most people encounter first when they look up the term. It develops after chronic inhalation of iron dust or fumes, and welders are the group at highest risk because their work generates fine iron oxide particles that penetrate deep into the airways.4PubMed Central. Occupational lung disease: a case of pulmonary siderosis in a welder worker Other at-risk workers include miners, foundry operators, and anyone who regularly grinds or polishes iron or steel.
On a chest X-ray or CT scan, the inhaled iron particles show up as small dense spots scattered through both lungs. These images can look alarming, but pulmonary siderosis has traditionally been classified as a benign form of pneumoconiosis. Unlike silicosis or asbestosis, it doesn’t typically cause the kind of progressive scarring that destroys lung tissue, and its radiological signs can partially or even nearly completely reverse once the worker is no longer exposed to iron dust.5PubMed Central. Pulmonary siderosis cases diagnosed with minimally invasive surgical technique: A retrospective analysis of 7 cases
That said, calling it benign can be misleading. Many welders are exposed to mixed fumes containing not just iron but also manganese, chromium, nickel, and other metals. In those cases, the lung disease may be more aggressive, and the term “welder’s lung” gets used loosely for conditions that aren’t pure siderosis. Even in cases of relatively pure iron exposure, some workers develop cough, shortness of breath on exertion, and reduced lung capacity over years. And there is growing evidence that chronic iron inhalation may contribute to systemic iron overload, meaning the iron doesn’t stay in the lungs. Case reports have documented welders with both pulmonary siderosis on lung biopsy and elevated iron stores throughout the body.6PubMed. Systemic iron overload associated with Welder’s siderosis
Treatment for pulmonary siderosis centers on removing the exposure. Workers who stop inhaling iron dust usually see improvement in symptoms and imaging findings over months to years. Beyond cessation, management is supportive: bronchodilators for airflow limitation, monitoring for complications, and screening for systemic iron overload in long-duration cases. On the prevention side, researchers have argued that occupational exposure limits specifically for welding fumes are overdue, and that engineering controls like local exhaust ventilation and respiratory protection are essential even where formal limits exist.7PubMed Central. An occupational exposure limit for welding fumes is urgently needed
Superficial Siderosis of the Central Nervous System
Superficial siderosis of the central nervous system is a different condition entirely. Here, iron accumulates not from external exposure but from repeated slow bleeding into the fluid-filled space surrounding the brain and spinal cord. This chronic or intermittent subarachnoid hemorrhage releases hemoglobin from red blood cells, which is eventually broken down into hemosiderin, an iron-storage compound that coats the surfaces of the brain, cerebellum, and cranial nerves like rust on a pipe.8PubMed. Superficial siderosis
The bleeding source can be surprisingly hard to find. Common causes include dural defects along the spine, tumors, previous surgery, or vascular malformations, but in some patients no source is ever identified.9PubMed. Superficial siderosis of the central nervous system associated with ventral dural defects Clinicians distinguish two subtypes based on where the hemosiderin deposits. The “classical” form, also called infratentorial superficial siderosis, primarily affects structures below the tentorium, meaning the cerebellum, brainstem, and spinal cord. A separate cortical form affects only the surface of the cerebral hemispheres and has different causes and clinical features.10BMJ Journals. Classical infratentorial superficial siderosis of the central nervous system: pathophysiology, clinical features and management
The classical form produces a recognizable triad of symptoms. The most common and often earliest complaint is progressive hearing loss, because the eighth cranial nerve is especially vulnerable to iron-mediated damage. This is followed by difficulty with balance and coordination (cerebellar ataxia) and eventually by weakness or stiffness in the limbs from spinal cord involvement.11PubMed. Superficial siderosis of central nervous system with unknown cause: report of 2 cases and review of the literature Cognitive decline can also develop as the condition progresses. The course is typically slow, unfolding over years to decades, but it is relentless if the bleeding source isn’t addressed.
MRI is the key diagnostic tool. On certain MRI sequences, hemosiderin deposits appear as a characteristic dark rim along the surfaces of the brain and spinal cord, and imaging the entire length of the spine is important because the bleeding source is often far from where the symptoms are worst.12American Journal of Roentgenology. Superficial siderosis of the CNS Treatment focuses on finding and stopping the bleed. When a dural tear or vascular anomaly is identified, surgical repair can halt progression in some patients, though damage already done to nerves and brain tissue is usually permanent. In cases where no bleeding source can be found, management is limited to symptomatic care, including hearing aids, physical therapy for balance, and rehabilitation.
Ocular Siderosis
Ocular siderosis occurs when an iron-containing foreign body becomes lodged inside the eye, usually after a penetrating injury. The classic scenario involves someone hammering metal and a tiny iron fragment flying into the eye, embedding itself in the vitreous cavity or retina. Over time, that fragment slowly corrodes, releasing iron ions that spread throughout the eye’s internal structures.13PubMed Central. Ocular siderosis: a misdiagnosed cause of visual loss due to ferrous intraocular foreign bodies
The timeline is unpredictable. Some patients develop signs within weeks; others harbor a retained foreign body for years before symptoms emerge. As iron infiltrates ocular tissues, it damages the retina, lens, and iris. Visible signs can include a brownish discoloration of the iris, a rusty cataract, and a dilated pupil that reacts poorly to light. The retina suffers quietly at first, with dysfunction starting in the inner retinal layers before spreading outward.14PubMed Central. Clinical observation and electroretinogram analysis of ocular siderosis following ocular trauma Left untreated, ocular siderosis can lead to severe and irreversible vision loss.
Specialized retinal function tests, particularly electroretinography, play an important role in catching the damage early, sometimes before the patient notices any visual change. Research has shown that more sensitive testing methods can detect subtle retinal impairment even when standard testing still looks normal.15Eye. Detection and monitoring of subclinical ocular siderosis using multifocal electroretinogram This matters because early detection gives the best chance of preserving vision.
Treatment means removing the foreign body, typically through a surgical procedure called pars plana vitrectomy. In one case series, retinal function testing showed improvement after surgery in about three-quarters of the eyes treated.16PubMed Central. Management of Ocular Siderosis: Visual Outcome and Electroretinographic Changes The sooner the metallic fragment is removed, the better the outcome. Once the iron has caused extensive damage to the retina and other structures, the lost function doesn’t come back. This is why any penetrating eye injury from metalwork should prompt imaging to rule out a retained foreign body, even if the initial injury seems minor.
Transfusional Iron Overload
People who depend on regular blood transfusions face a different path to siderosis. Each unit of transfused red blood cells delivers a significant dose of iron, and the human body has no efficient mechanism for excreting large amounts of it. Over dozens or hundreds of transfusions, iron accumulates in the liver, heart, and endocrine glands. Untreated, this progressive loading leads to liver scarring, hormonal disruptions, cardiac rhythm abnormalities, heart failure, and shortened life expectancy.17PubMed Central. Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
The patients most affected are those with conditions requiring chronic transfusion support, such as thalassemia major, sickle cell disease, and certain bone marrow failure syndromes. For these patients, iron chelation therapy is a critical part of their ongoing care. Three chelating drugs have been extensively studied: deferoxamine, which is given by slow infusion; deferasirox, an oral tablet; and deferiprone, another oral option with a different availability profile depending on the country.17PubMed Central. Management of transfusional iron overload – differential properties and efficacy of iron chelating agents Each drug has its own set of side effects and strengths. Some are better at clearing iron from the heart; others work more effectively in the liver. Choosing between them requires balancing the patient’s specific iron burden, organ involvement, tolerance for side effects, and willingness to comply with the dosing schedule.
Monitoring iron levels is done through blood tests (serum ferritin is the simplest) and, increasingly, through specialized MRI techniques that can estimate the iron concentration in the heart and liver without needing a biopsy. The goal of chelation is not to eliminate all iron from the body but to keep it at levels where organ damage doesn’t progress. For patients who start chelation early and stick with it, outcomes have improved dramatically over recent decades.
Renal Siderosis
The kidneys can accumulate iron too, though this form of siderosis gets less attention than the others. It develops as a consequence of chronic intravascular hemolysis, meaning ongoing destruction of red blood cells within the bloodstream. When red cells break apart, they release free hemoglobin. Normally, a blood protein called haptoglobin binds this hemoglobin and escorts it to the liver for safe recycling. But when hemolysis is severe or persistent, haptoglobin becomes saturated, and the excess free hemoglobin spills into the kidneys via the glomerular filtration process. In the kidney tubules, this hemoglobin is broken down and the released iron is stored as hemosiderin, gradually building up in the tubular cells.18PubMed Central. Renal hemosiderosis secondary to intravascular hemolysis after mitral valve repair
Conditions that cause chronic hemolysis and put the kidneys at risk include mechanical heart valves (especially older models or malfunctioning ones), paroxysmal nocturnal hemoglobinuria, and certain severe anemias. Symptoms of renal siderosis itself are often subtle and overshadowed by the underlying hemolytic disorder, but over time, the iron deposits can contribute to tubular dysfunction and impaired kidney function. Diagnosis typically comes from MRI findings showing signal changes in the kidney cortex or from biopsy showing hemosiderin-laden tubular cells. Treatment focuses on correcting or minimizing the hemolysis where possible, since the kidney iron loading is a downstream consequence.
Dietary Iron Overload
In parts of sub-Saharan Africa, a distinct pattern of iron overload has been recognized for decades. It results from the consumption of large quantities of traditional home-brewed beer fermented in iron pots or drums, which leaches substantial amounts of iron into the beverage.19PubMed. Dietary iron overload in the African and hepatocellular carcinoma Individuals who drink this beer regularly can ingest far more iron than the body can safely store, and the excess accumulates primarily in the liver and spleen. This form of siderosis has been linked to liver scarring and an elevated risk of liver cancer, making it a serious public health concern in affected communities.
Dietary iron overload from this traditional brewing practice is distinct from hereditary hemochromatosis, a genetic condition that also causes the body to absorb and store too much iron. Research has explored whether shared genetic factors might contribute to both conditions, particularly variants of the HFE gene, but the data remain mixed.20PubMed Central. HFE gene in primary and secondary hepatic iron overload It’s likely that in some individuals a genetic predisposition to absorb excess iron combines with high dietary intake to produce a more severe overload than either factor alone would cause. For clinicians, distinguishing between dietary, genetic, and transfusional causes of hepatic iron loading matters because the treatment strategy differs: reducing iron intake may suffice for dietary cases, while genetic hemochromatosis requires therapeutic phlebotomy and transfusional overload requires chelation.
Siderotic Nodules in the Spleen
There is yet another context in which clinicians encounter the word “siderosis” and its relatives. In patients with portal hypertension, often from cirrhosis, the spleen develops small organized pockets of old hemorrhage called Gamna-Gandy bodies, also known as siderotic nodules. These nodules contain hemosiderin alongside fibrous tissue and calcium, the remnants of tiny bleeds within the splenic tissue.21PubMed. Gamna-Gandy bodies: a sign of portal hypertension
On ultrasound, they appear as scattered bright spots in the spleen. On MRI, the hemosiderin causes characteristic dark foci on certain sequences, which helps confirm the diagnosis.22PubMed. Gamna-Gandy bodies of the spleen: evaluation with MR imaging Gamna-Gandy bodies themselves don’t cause symptoms and don’t require treatment, but their presence is a useful diagnostic clue. Finding them tells the clinician that portal hypertension is present and may prompt further investigation into the health of the liver and the portal venous system. They’re an incidental finding that points toward a larger problem rather than being a problem in their own right.
How the Different Forms Are Diagnosed
Because siderosis can affect so many organs, there’s no single test for it. The diagnostic approach depends entirely on which form is suspected.
- Pulmonary siderosis: Chest imaging (X-ray or CT) showing characteristic dense nodules in a worker with relevant occupational exposure. Lung biopsy confirming iron-laden macrophages can be definitive but is rarely needed when the clinical picture is clear.
- Superficial siderosis of the CNS: MRI of the brain and entire spinal cord, looking for the telltale dark rim of hemosiderin along neural surfaces. Finding the bleeding source often requires additional imaging, including MRI myelography or CT angiography.
- Ocular siderosis: Clinical eye exam (looking for iris discoloration, cataract, pupil changes) combined with imaging to locate a foreign body and electroretinography to assess retinal function.
- Transfusional overload: Serum ferritin levels and specialized MRI techniques that quantify iron in the liver and heart. Liver biopsy with iron staining was once the gold standard but has been largely replaced by noninvasive imaging.
- Renal siderosis: MRI showing signal changes in the kidney cortex, supported by clinical evidence of chronic hemolysis (low haptoglobin, elevated LDH, hemoglobinuria).
In all forms, the key is recognizing the clinical context that makes iron deposition plausible, whether it’s an occupation, a transfusion history, a traumatic eye injury, or signs of chronic bleeding. Siderosis is not one disease but a family of conditions tied together by the same element behaving badly in the wrong place.
When Siderosis Is Reversible and When It Isn’t
The prognosis varies sharply across forms. Pulmonary siderosis is often the most forgiving: remove the exposure and the lungs can clear much of the iron over time, with imaging abnormalities fading and symptoms improving.5PubMed Central. Pulmonary siderosis cases diagnosed with minimally invasive surgical technique: A retrospective analysis of 7 cases Ocular siderosis caught early and treated with prompt surgical removal of the foreign body also has a reasonable prognosis, with most patients seeing improvement in retinal function afterward.16PubMed Central. Management of Ocular Siderosis: Visual Outcome and Electroretinographic Changes Transfusional iron overload, while not reversible in the sense that the underlying need for transfusions goes away, is manageable with chelation therapy, and cardiac and hepatic iron can be meaningfully reduced with consistent treatment.
Superficial siderosis of the CNS is the most frustrating. The neurological damage from hemosiderin deposits on brain and nerve surfaces tends to be permanent, and even when the bleeding source is found and repaired, the hearing loss, ataxia, and cognitive changes already present rarely improve. The goal of surgical treatment is stabilization, not recovery. For patients in whom no bleeding source is identified, the condition simply continues its slow progression. This stark difference in reversibility underscores why early recognition matters: the same element causing a largely reversible occupational lung condition in one patient can cause irreversible neurological disability in another.